Pharma Reaserch Prod Co Ltd Net Assets

Latest as of December 2025: ₩723.88 Billion KRW ≈ $490.56 Million USD

Pharma Reaserch Prod Co Ltd net assets. Based on the latest financial reports, Pharma Reaserch Prod Co Ltd (214450) has net assets worth ₩723.88 Billion KRW (≈ $490.56 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩1.04 Trillion ≈ $707.43 Million USD) and total liabilities (₩320.01 Billion ≈ $216.87 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Pharma Reaserch Prod Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩723.88 Billion
% of Total Assets	69.34%
Annual Growth Rate	16.53%
5-Year Change	136.99%
10-Year Change	321.74%
Growth Volatility	9.56

Net Assets of Pharma Reaserch Prod Co Ltd (2015–2025)

Net assets of Pharma Reaserch Prod Co Ltd from 2015 to 2025. This chart illustrates how Pharma Reaserch Prod Co Ltd's net assets have evolved over time, based on quarterly financial data. See 214450 equity to assets ratio to measure how much of total assets are equity-financed.

Annual Net Assets for Pharma Reaserch Prod Co Ltd (2015–2025)

The table below shows the annual net assets of Pharma Reaserch Prod Co Ltd from 2015 to 2025. For live market cap and overall valuation, see how much is Pharma Reaserch Prod Co Ltd worth.

Year	Net Assets	Change
2025-12-31	₩723.88 Billion ≈ $490.56 Million	+27.12%
2024-12-31	₩569.44 Billion ≈ $385.90 Million	+23.20%
2023-12-31	₩462.19 Billion ≈ $313.22 Million	+34.55%
2022-12-31	₩343.50 Billion ≈ $232.79 Million	+12.46%
2021-12-31	₩305.44 Billion ≈ $206.99 Million	+24.46%
2020-12-31	₩245.42 Billion ≈ $166.32 Million	+17.39%
2019-12-31	₩209.07 Billion ≈ $141.69 Million	+5.79%
2018-12-31	₩197.62 Billion ≈ $133.93 Million	+10.50%
2017-12-31	₩178.85 Billion ≈ $121.21 Million	+4.20%
2016-12-31	₩171.64 Billion ≈ $116.32 Million	+9.50%
2015-12-31	₩156.75 Billion ≈ $106.23 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Pharma Reaserch Prod Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 1312.2% over the analyzed period, indicating profitable operations and earnings retention.

Pharma Reaserch Prod Co Ltd Net Assets Breakdown (December 2025)

Pharma Reaserch Prod Co Ltd net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Retained Earnings	₩492.07 Billion	71.38%
Other Components	₩197.26 Billion	28.62%
Total Equity	₩689.33 Billion	100.00%

Pharma Reaserch Prod Co Ltd Competitors by Market Cap

The table below lists competitors of Pharma Reaserch Prod Co Ltd ranked by their market capitalization.

Company	Market Cap
Suzhou Crystal Clear Chemical Co Ltd SHE:300655	$1.49 Billion
Global Blue Group Holding Ltd NYSE:GB	$1.49 Billion
First Tracks Biotherapeutics NASDAQ:TRAX	$1.49 Billion
SkiStar AB (publ) ST:SKIS-B	$1.49 Billion
China National Accord Medicines Corp Ltd SHE:000028	$1.49 Billion
Neutron Holdings, Inc. Common Stock NASDAQ:LIME	$1.49 Billion
Grupo Security SN:SECURITY	$1.49 Billion
China Aluminum International Engineering Corp Ltd SHG:601068	$1.49 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Pharma Reaserch Prod Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 539,402,310,120 to 689,331,204,110, a change of 149,928,893,990 (27.8%).
Net income of 165,120,956,450 contributed positively to equity growth.
Dividend payments of 11,728,612,800 reduced retained earnings.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩165.12 Billion	+23.95%
Dividends Paid	₩11.73 Billion	-1.7%
Other Changes	₩-3.46 Billion	-0.5%
Total Change	₩-	27.80%

Book Value vs Market Value Analysis

This analysis compares Pharma Reaserch Prod Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 3.20x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 11.61x to 3.20x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩18256.70	₩212000.00	x
2017-12-31	₩19149.48	₩212000.00	x
2018-12-31	₩20891.66	₩212000.00	x
2019-12-31	₩22197.68	₩212000.00	x
2020-12-31	₩25424.35	₩212000.00	x
2021-12-31	₩30617.97	₩212000.00	x
2022-12-31	₩34433.26	₩212000.00	x
2023-12-31	₩42492.31	₩212000.00	x
2024-12-31	₩52145.39	₩212000.00	x
2025-12-31	₩66347.89	₩212000.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Pharma Reaserch Prod Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 23.95%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 30.79%
• Asset Turnover: 0.51x
• Equity Multiplier: 1.51x
Recent ROE (23.95%) is above the historical average (12.54%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2015	8.22%	34.38%	0.22x	1.08x	₩-2.80 Billion
2016	8.10%	30.27%	0.26x	1.04x	₩-3.26 Billion
2017	7.24%	23.78%	0.29x	1.06x	₩-4.93 Billion
2018	7.29%	22.41%	0.25x	1.31x	₩-5.35 Billion
2019	7.97%	19.87%	0.31x	1.29x	₩-4.24 Billion
2020	13.35%	30.14%	0.34x	1.30x	₩8.23 Billion
2021	15.29%	30.30%	0.36x	1.40x	₩16.14 Billion
2022	11.81%	20.83%	0.41x	1.39x	₩6.23 Billion
2023	17.68%	29.33%	0.49x	1.24x	₩33.24 Billion
2024	17.06%	26.29%	0.41x	1.59x	₩38.10 Billion
2025	23.95%	30.79%	0.51x	1.51x	₩96.19 Billion

Industry Comparison

This section compares Pharma Reaserch Prod Co Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $335,514,290,493
Average return on equity (ROE) among peers: -13.65%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Pharma Reaserch Prod Co Ltd (214450)	₩723.88 Billion	8.22%	0.44x	$1.49 Billion
ORIENTBIO Inc. (002630)	$62.29 Billion	1.41%	1.19x	$95.63 Million
Green Cross (005250)	$1.38 Trillion	3.43%	0.63x	$278.32 Million
Green Cross Holdings Preference Shares (005257)	$1.10 Trillion	3.96%	0.48x	$2.77 Million
Pharmicell (005690)	$82.82 Billion	-21.94%	0.22x	$382.24 Million
GeneOne Life Science Inc (011000)	$23.71 Billion	-35.27%	0.34x	$32.81 Million
HLB Co. Ltd (028300)	$582.25 Billion	-32.21%	0.29x	$3.60 Billion
Mgenplus Co. Ltd. (032790)	$33.69 Billion	-48.34%	0.78x	$20.36 Million
Daesung Microbiological Labs. Co. Ltd (036480)	$19.73 Billion	2.26%	0.29x	$14.14 Million
Seoulin Bioscience Co.Ltd (038070)	$51.49 Billion	4.00%	0.38x	$21.33 Million
Hyundai Bioscience Co. Ltd (048410)	$22.49 Billion	-13.82%	0.46x	$351.19 Million

About Pharma Reaserch Prod Co Ltd

KQ:214450 Korea Biotechnology

Market Cap

$1.49 Billion

₩2.20 Trillion KRW

Market Cap Rank

#6965 Global

#165 in Korea

Share Price

₩212000.00

Change (1 day)

-4.72%

52-Week Range

₩212000.00 - ₩540000.00

All Time High

₩711000.00